News

ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones

KEY HIGHLIGHTS First clinical site for Phase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with ...

Kay Properties & Investments Adds New Build-to-Rent Delaware Statutory Trust Offering to Its Premier Online 1031 Exchange Marketplace

Kay Properties & Investments, a leading national real estate wealth management firm specializing in Delaware Statutory Trust ...